Long Non-Coding RNA SNHG22 in Prognosis for Solid Tumors: A Systematic Review and Meta-Analysis

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Systematic review reveals that high SNHG22 levels worsen prognosis in solid tumors, suggesting an oncogenic role.

Patients with SNHG22 overexpression showed poorer overall survival, indicating its prognostic significance.
The hazard ratio for recurrence-free survival was 2.60, highlighting the link between SNHG22 and cancer outcomes.
Higher SNHG22 expression correlated with larger tumor size and lymph node metastasis, emphasizing its role in progression.
This pooled analysis included nine studies, providing a robust estimation of SNHG22's impact on tumor prognosis.

Phan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark